Review
The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI
Bhuvnesh Aggarwal, MD, Sachin S. Goel, MD, Joseph F. Sabik, MD and Mehdi H. Shishehbor, DO, MPH, PhD
Cleveland Clinic Journal of Medicine August 2013, 80 (8) 515-523; DOI: https://doi.org/10.3949/ccjm.80a.13030
Bhuvnesh Aggarwal
Department of Internal Medicine, Cleveland Clinic
Sachin S. Goel
Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic
Joseph F. Sabik
Chair, Department of Thoracic and Cardiovascular Surgery; Staff, Critical Care Center, Heart and Vascular Institute, Cleveland Clinic; and Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
Mehdi H. Shishehbor
Director, Endovascular Services, Interventional Cardiology and Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic

Article Information
vol. 80 no. 8 515-523
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 1, 2013.
Copyright & Usage
Copyright © 2013 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 80, Issue 8
1 Aug 2013
The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI
Bhuvnesh Aggarwal, Sachin S. Goel, Joseph F. Sabik, Mehdi H. Shishehbor
Cleveland Clinic Journal of Medicine Aug 2013, 80 (8) 515-523; DOI: 10.3949/ccjm.80a.13030
Jump to section
Related Articles
- No related articles found.